医学
传统PCI
心源性休克
心脏病学
经皮冠状动脉介入治疗
蒂米
内科学
血运重建
冠状动脉疾病
狭窄
心肌梗塞
血管成形术
罪魁祸首
单变量分析
外科
多元分析
作者
Alex F. Castro‐Mejía,María Elizabeth Ortega-Armas,Hernán Mejía‐Rentería,Nieves Gonzalo,Pablo Salinas,Luis Nombela‐Franco,María Del Trigo,Pilar Jiménez‐Quevedo,Javier Escaned,Antonio Fernández-Ortı́z,Carlos Macaya,Iván J. Núñez‐Gil
摘要
Abstract Background Percutaneous coronary intervention (PCI) of left main (LM) disease in patients with cardiogenic shock (CS) represents a clinical challenge. Evidence on clinical outcomes according to revascularization strategies in this scenario remains scarce. The objective was to investigate the short‐term outcomes according to treatment strategies for this population. Methods We retrospectively analyzed 78 consecutive patients who underwent PCI of LM in established CS at two experienced centers. Characteristics of PCI and short‐term clinical outcomes were assessed. Results LM stenosis was considered the culprit lesion in 49 patients (62.8%). In the remaining cases, LM stenosis was treated after successful PCI of the culprit vessel because of persistent CS. The majority of patients presented complex coronary anatomy (43.6% had Syntax score > 32). Complete revascularization was performed in 34.6%; a 2‐stents technique in the LM bifurcation was used in 12.8% and intra‐aortic balloon pump (IABP) in 73.1%. In‐hospital mortality was 48.7%. At 90 days follow‐up it was 50% without differences between 1 or 2 stent LM bifurcation‐techniques ( p = .319). Mortality was higher in patients with partial revascularization and residual Syntax score ≥ 15 ( p < .05 by univariate analysis), and in those with TIMI flow<3 in the left coronary artery at the end of PCI ( p < .05 by multivariate analysis). There were no significant differences in the use of IABP in relation to 90‐day mortality ( p = .92). Conclusions In patients presenting with cardiogenic shock and LM disease, neither 2‐stents strategy in the LM nor use of IABP displayed a reduced short‐term mortality. However, patients with final TIMI flow <3 presented higher short‐term mortality in our series.
科研通智能强力驱动
Strongly Powered by AbleSci AI